About Acurx Pharmaceuticals, Inc. - Common Stock (ACXP)
Acurx Pharmaceuticals Inc is a biopharmaceutical company focused on developing novel antimicrobial therapies to combat bacterial infections, particularly those caused by antibiotic-resistant pathogens. The company is engaged in research and development of innovative drug candidates that address critical unmet medical needs in the treatment of serious infections. With a commitment to advancing therapeutic options, Acurx aims to improve patient outcomes through its proprietary drug formulations and scientific expertise. The company's efforts are geared toward not only treating existing infections but also preventing the spread of multidrug-resistant bacteria in healthcare settings. Read More
In today’s MAGA Stocks Undercard lineup, a select group of small-cap innovators are reshaping the landscapes of social media, biotech, and blockchain technology. These companies—each positioned at the forefront of next-generation disruption—are demonstrating renewed investor confidence and sector-wide momentum heading into Q4.
Looking for insights into the US markets one hour before the close of the markets on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Wednesday. Let's explore the market movements and identify the stocks with significant gaps.
NEW YORK CITY, NEW YORK / ACCESS Newswire / October 6, 2025 / New to The Street, one of America's longest-running business television brands, announces tonight's nationwide broadcast on Fox Business at 10:30 PM PST. The episode features exclusive interviews with NeOnc Technologies (NASDAQ:NTHI), FLOKI, XION, Sharps Technology (NASDAQ:STSS), and Aeries Technology (NASDAQ:AERT), each highlighting their innovation, growth, and leadership in their respective sectors.
Sponsored Programming Featuring Commercials by Laser Photonics Corp. (NASDAQ:LASE), Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP), PetVivo Holdings, Inc. (NASDAQ:PETV), DataVault AI (NASDAQ:DVLT), and The Sustainable Green Team (OTCQX:SGTM)
Bloomberg Television 6:30 PM ET as Sponsored Programming - With TV Commercials Debuting by Laser Photonics $LASE, Synergy CHC $SNYR, Sustainable Green Team $SGTM, and Acurx Pharmaceuticals $ACXP
NEW YORK CITY, NY / ACCESS Newswire / September 13, 2025 / New to The Street, one of America's longest-running financial media television platforms, will air its 686th episode nationwide on Bloomberg Television tonight, Saturday, September 13, 2025, at 6:30 PM EST.
NEW YORK CITY, NY / ACCESS Newswire / September 6, 2025 / New to The Street, one of the nation's premier financial media platforms, today announced that Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP), a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, has re-signed for a comprehensive media partnership.
Sponsored TV commercials by NRx Pharma (NASDAQ:NRXP), Synergy CHC (NASDAQ:SNYR), ACURX Pharmaceuticals (NASDAQ:ACXP), and Sustainable Green Team (OTCQX:SGTM).
Cross-platform synergy across NTTS TV, cable, social media, and NewsOut video press release amplification is delivering record-breaking visibility for public companies
Show Number 675 is sponsored programming by Ainos (NASDAQ: AIMD), Arrive AI ($ARAI), Acurx Pharmaceuticals (NASDAQ: ACXP), Sustainable Green Team (OTC: SGTM) and Commercialville T.V. commercials
The regular session of the US market on Tuesday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
